Life-Extending Breast Cancer Drug Secured for NHS Patients in England
Quick Brief
Following a successful pricing agreement between government ministers and the manufacturer, the life-extending medication Enhertu will be provided on the NHS in England. An initial decision regarding the treatment had previously been rejected, but the new accord reverses that stance. Approximately 1,000 women annually with a specific advanced form of the disease are expected to benefit.
What Happened?
Ministers and the makers of the medication Enhertu reached a pricing agreement, clearing the way for the treatment to be prescribed through the National Health Service in England. This reverses an earlier decision that rejected the therapy. The drug is set to become accessible starting Thursday, granting about 1,000 women per year with HER2-low advanced breast cancer a new avenue for care. Meanwhile, the treatment has already been available in Scotland for over two years.
Why It Matters
The inclusion of Enhertu on the NHS offers renewed hope for patients facing incurable advanced breast cancer, providing an average of an extra seven months of life. The pricing deal resolves previous cost barriers that had kept the medication from being offered to patients in England.
Key Facts
- Enhertu will be available on the NHS in England starting Thursday.
- The agreement follows a successful new round of pricing negotiations between ministers and the drug's manufacturers.
- Approximately 1,000 women a year with HER2-low advanced breast cancer will be eligible for the medication.
- The treatment can extend patient lives by an average of seven months.
- The medication has already been prescribed in Scotland for more than two years.
Compiled from 4 outlets
Related Stories
Measles Outbreak in Bangladesh Claims Lives of Over 1,000 Children
A severe measles outbreak in Bangladesh has resulted in the deaths of over 1,000 children. This tragic toll reverses the substantial progress the country had made toward eliminating the disease as of March this year.
Fiji Declares National HIV Emergency Amid Rising Infections and Methamphetamine Use
Fiji has officially declared a national HIV emergency following a significant increase in infections linked to rising methamphetamine use. Health authorities report that standard outbreak responses are no longer adequate for the escalating epidemic.
Tuberculosis Case Confirmed at Cumberland County High School
Health and school officials are investigating a confirmed case of tuberculosis at Seventy-First High School in Fayetteville, North Carolina. Authorities report that more than 260 individuals may have been exposed to the illness.
Common Osteoporosis Medications Linked to Decreased Alzheimer's Risk in Large Study
A recent observational study involving 120,000 adults has uncovered a potential neurological benefit tied to standard bone health treatments. Researchers found that common medications used for osteoporosis are associated with a substantially reduced risk of Alzheimer's disease.